Concepedia

Maral Amangurbanova

MA

Statistics

Publications

9

Citations

389

H-Index

9

Active since

2020

Affiliations

University of California San Diego(Current)

National University of Singapore

National University Health System

Beth Israel Deaconess Medical Center

Cleveland Clinic

Maral Amangurbanova is an author at University of California San Diego specializing in medicine, hepatology, and liver disease.

Publications per year

2020–2025

9

Publications

9

Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study

Daniel Q. Huang, Laura Wilson, Cynthia Behling et al. · Gastroenterology · 2023 · 167 citations · Full text

Medicine, Internal Medicine, Pathology +17

Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA

Alexander H. Yang, Monica A. Tincopa, Federica Tavaglione et al. · Gut · 2024 · 55 citations · Full text

Medicine, Internal Medicine, Radiology +15

Head‐to‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of <scp>MetALD</scp> Versus <scp>MASLD</scp>: A Prospective Study

Federica Tavaglione, Maral Amangurbanova, Alexander H. Yang et al. · Alimentary Pharmacology & Therapeutics · 2025 · 38 citations · Full text

Medicine, Toxicology, Hepatology +16

MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH

Rohit Loomba, Maral Amangurbanova, Ricki Bettencourt et al. · Gut · 2024 · 36 citations · Full text

Medicine, Pathology, Radiology +17

Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes

Selena Z. Kuo, Sandra Cepin, Jaclyn Bergstrom et al. · Alimentary Pharmacology & Therapeutics · 2023 · 26 citations · Full text

Medicine, Chronic Disease Prevention, Clinical Cardiology +16

1–5 of 9